Modulation of autoimmune diseases by nitric oxide

Nitric oxide (NO) is an intercellular messenger that performs a number of functions, including neurotransmission, vasodilatation, inhibition of platelet aggregation, and modulation of leukocyte adhesion. NO has recently been shown to act as a potent cytotoxic effector molecule as well as to play an important role in the pathogenesis of organ-specific autoimmunity. NO may also modulate the immune response by interfering with Th1/Th2 balance in autoimmune diseases. This review will discuss the role of NO and nitric oxide synthase (NOS) in pathophysiologic and therapeutic implications in various autoimmune diseases with particular reference to T helper-1 (Th1) and T helper-2 (Th2) cytokines.

[1]  T. Sunyer,et al.  Proinflammatory agents, IL‐8 and IL‐10, upregulate inducible nitric oxide synthase expression and nitric oxide production in avian osteoclast‐like cells , 1996, Journal of cellular biochemistry.

[2]  D. Lawrence,et al.  Metal-induced modulation of nitric oxide production in vitro by murine macrophages: lead, nickel, and cobalt utilize different mechanisms. , 1996, Toxicology and applied pharmacology.

[3]  M. Seldin,et al.  The role of nitric oxide in the pathogenesis of spontaneous murine autoimmune disease: increased nitric oxide production and nitric oxide synthase expression in MRL-lpr/lpr mice, and reduction of spontaneous glomerulonephritis and arthritis by orally administered NG-monomethyl-L- arginine , 1994, The Journal of experimental medicine.

[4]  A. Vladutiu,et al.  Role of nitric oxide in autoimmunity. , 1995, Clinical immunology and immunopathology.

[5]  J. Parel,et al.  Reduction of corneal edema in endotoxin-induced uveitis after application of L-NAME as nitric oxide synthase inhibitor in rats by iontophoresis. , 1998, Investigative ophthalmology & visual science.

[6]  S. Snyder,et al.  Isolation of nitric oxide synthetase, a calmodulin-requiring enzyme. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[7]  M. T. Bengoechea-Alonso,et al.  Inducible nitric oxide synthase (iNOS) expression in human monocytes triggered by beta-endorphin through an increase in cAMP. , 1998, Biochemical and biophysical research communications.

[8]  H. Kolb,et al.  Nitric oxide in autoimmune disease: cytotoxic or regulatory mediator? , 1998, Immunology today.

[9]  F. Fang.  Perspectives series: host/pathogen interactions. Mechanisms of nitric oxide-related antimicrobial activity. , 1997, The Journal of clinical investigation.

[10]  E. Garvey,et al.  High-level expression of human inducible nitric oxide synthase in Chinese hamster ovary cells and characterization of the purified enzyme. , 1996, Biochemical and biophysical research communications.

[11]  Yang Wang,et al.  Structural organization of the human neuronal nitric oxide synthase gene (NOS1). , 1994, The Journal of biological chemistry.

[12]  C. S. Park,et al.  An unprocessed pseudogene of inducible nitric oxide synthase gene in human. , 1997, Nitric oxide : biology and chemistry.

[13]  C. Nathan,et al.  Nitric oxide as a secretory product of mammalian cells , 1992, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[14]  M. Nehls,et al.  Suppression of Apoptosis by Nitric Oxide via Inhibition of Interleukin-1β–converting Enzyme (ICE)-like and Cysteine Protease Protein (CPP)-32–like Proteases , 1997, The Journal of experimental medicine.

[15]  C. Lowenstein,et al.  Nitric Oxide: A Physiologic Messenger , 1994, Annals of Internal Medicine.

[16]  E. Hoffman,et al.  Molecular cloning, structure, and chromosomal localization of the human inducible nitric oxide synthase gene. , 1994, The Journal of biological chemistry.

[17]  D. Laskin,et al.  Multifunctional role of nitric oxide in inflammation , 1994, Trends in Endocrinology & Metabolism.

[18]  S. Moncada,et al.  Nitric oxide: physiology, pathophysiology, and pharmacology. , 1991, Pharmacological reviews.

[19]  M. Shimaoka,et al.  Nitric oxide induces apoptosis in mouse splenic T lymphocytes. , 1996, Immunology letters.

[20]  S H Snyder,et al.  Molecular cloning and expression of inducible nitric oxide synthase from human hepatocytes. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[21]  O. Bagasra,et al.  Prevention of experimental allergic encephalomyelitis by targeting nitric oxide and peroxynitrite: implications for the treatment of multiple sclerosis. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[22]  K. Adler,et al.  Nitric oxide synthase inhibitors exert differential time-dependent effects on LPS-induced uveitis. , 1996, Experimental eye research.

[23]  R L Guyer,et al.  The molecule of the year. , 1989 .

[24]  G. Gilkeson,et al.  Effect of late modulation of nitric oxide production on murine lupus. , 1997, Clinical immunology and immunopathology.

[25]  S. Wahl,et al.  Suppression of arthritis by an inhibitor of nitric oxide synthase , 1993, The Journal of experimental medicine.

[26]  J. Hevel,et al.  Tissue injury caused by deposition of immune complexes is L-arginine dependent. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[27]  S. Moncada,et al.  Modulation of adjuvant arthritis by endogenous nitric oxide , 1993, British journal of pharmacology.

[28]  C. Haggerty,et al.  Alternative Splicing of Human Inducible Nitric-Oxide Synthase mRNA , 1996, The Journal of Biological Chemistry.

[29]  H. Esumi,et al.  Structural diversity of neuronal nitric oxide synthase mRNA in the nervous system. , 1993, Biochemical and biophysical research communications.

[30]  G. Makhlouf,et al.  Expression of endothelial nitric oxide synthase in human and rabbit gastrointestinal smooth muscle cells. , 1998, The American journal of physiology.

[31]  K. Kröncke,et al.  Nitric oxide: cytotoxicity versus cytoprotection--how, why, when, and where? , 1997, Nitric oxide : biology and chemistry.

[32]  H. Kolb,et al.  Transcription and translation of inducible nitric oxide synthase in the pancreas of prediabetic BB rats , 1993, FEBS letters.

[33]  C. Bogdan.  The Multiplex Function of Nitric Oxide in (Auto)immunity , 1998, The Journal of experimental medicine.

[34]  C. Nathan,et al.  Regulation of biosynthesis of nitric oxide. , 1994, The Journal of biological chemistry.

[35]  T. Quertermous,et al.  Cloning and expression of a cDNA encoding human endothelium-derived relating factor/nitric oxide synthase. , 1992, The Journal of biological chemistry.

[36]  K. Kröncke,et al.  Endothelial cells as cytotoxic effector cells: cytokine-activated rat islet endothelial cells lyse syngeneic islet cells via nitric oxide , 1997, Diabetologia.

[37]  I. Charles,et al.  Altered immune responses in mice lacking inducible nitric oxide synthase , 1995, Nature.

[38]  Y. Hattori,et al.  SECRETION OF TNF-α, IL-8 AND NITRIC OXIDE BY MACROPHAGES ACTIVATED WITH POLYANIONS, AND INVOLVEMENT OF INTERFERON-γ IN THE REGULATION OF CYTOKINE SECRETION , 1999 .

[39]  M. Denis.  Journal of Leukocyte Biology 49:380-387 (1991) Tumor Necrosis Factor and Granulocyte Macrophage- Colony Stimulating Factor Stimulate Human Macrophages to Restrict Growth of Virulent Mycobacterium avium and to Kill Avirulent M. avium: Killing Effector Mech , 2022 .

[40]  P. Marsden,et al.  Cloning and characterization of murine endothelial constitutive nitric oxide synthase. , 1996, Biochimica et biophysica acta.

[41]  L. Overbergh,et al.  Effect of staphylococcal enterotoxin B injection on the development of experimental autoimmune encephalomyelitis: influence of cytokine and inducible nitric oxide synthase production , 1999, Journal of Neuroimmunology.

[42]  F. Takano,et al.  Flavonoids from Cleome droserifolia suppress NO production in activated macrophages in vitro. , 1999, Planta medica.

[43]  F. Liew,et al.  Effects of nitric oxide on the induction and differentiation of Th1 cells , 1999, European journal of immunology.

[44]  H. Kolb,et al.  Strategies of protection from nitric oxide toxicity in islet inflammation , 1999, Journal of Molecular Medicine.

[45]  D. Gold,et al.  Inhibition of inducible nitric oxide synthase intensifies injury and functional deterioration in autoimmune interstitial nephritis. , 1997, Journal of immunology.

[46]  S. Bertholet,et al.  Expression of the inducible NO synthase in human monocytic U937 cells allows high output nitric oxide production , 1999, Journal of leukocyte biology.

[47]  G. Kroemer,et al.  Cytokines and autoimmune disease. , 1991, Clinical immunology and immunopathology.

[48]  H. Heng,et al.  Localization of the human gene for inducible nitric oxide synthase (NOS2) to chromosome 17q11.2-q12. , 1994, Genomics.

[49]  A. Cross,et al.  Inducible nitric oxide synthase gene expression and enzyme activity correlate with disease activity in murine experimental autoimmune encephalomyelitis , 1996, Journal of Neuroimmunology.

[50]  N. Welsh,et al.  Cytokines suppress human islet function irrespective of their effects on nitric oxide generation. , 1994, The Journal of clinical investigation.

[51]  M. Murphy,et al.  Enhanced mitochondrial radical production in patients which rheumatoid arthritis correlates with elevated levels of tumor necrosis factor alpha in plasma. , 1996, Free radical research.

[52]  S. Weremowicz,et al.  Isolation and chromosomal localization of the human endothelial nitric oxide synthase (NOS3) gene. , 1994, Genomics.

[53]  Alfred Hausladen,et al.  Nitrosative Stress: Activation of the Transcription Factor OxyR , 1996, Cell.

[54]  O. Feron,et al.  Nitric oxide synthases: which, where, how, and why? , 1997, Journal of Clinical Investigation.

[55]  T. Sakamoto,et al.  Molecular cloning and characterization of Ca2+-dependent inducible nitric oxide synthase from guinea-pig lung. , 1998, The Biochemical journal.

[56]  V. Singh,et al.  Experimental autoimmune uveitis as animal model for human posterior uveitis. , 1998, The Indian journal of medical research.

[57]  E. Unanue,et al.  Nitric oxide production in islets from nonobese diabetic mice: aminoguanidine-sensitive and -resistant stages in the immunological diabetic process. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[58]  V. Badovinac,et al.  Cell‐specific effects of pentoxifylline on nitric oxide production and inducible nitric oxide synthase mRNA expression , 1997, Immunology.

[59]  R. Andersson,et al.  Modulation of P-selectin expression on isolated human platelets by an NO donor assessed by a novel ELISA application. , 1997, Journal of immunological methods.

[60]  D. Gold,et al.  Nitric oxide in interstitial nephritis and other autoimmune diseases. , 1999, Seminars in nephrology.

[61]  L. Ignarro,et al.  Cutting Edge: Antisense Knockdown of Inducible Nitric Oxide Synthase Inhibits Induction of Experimental Autoimmune Encephalomyelitis in SJL/J Mice , 1998, The Journal of Immunology.

[62]  G. Schuler,et al.  Complete coding sequence of inducible nitric oxide synthase from human heart and skeletal muscle of patients with chronic heart failure. , 1998, Nitric oxide : biology and chemistry.

[63]  Terry D. Lee,et al.  Cloning and characterization of inducible nitric oxide synthase from mouse macrophages. , 1992, Science.

[64]  D. Celermajer,et al.  L-arginine reduces human monocyte adhesion to vascular endothelium and endothelial expression of cell adhesion molecules. , 1997, Circulation.

[65]  M. Lai,et al.  Nitric oxide increased interleukin‐4 expression in T lymphocytes , 1997, Immunology.

[66]  M. Belosevic,et al.  A partial sequence for nitric oxide synthase from a goldfish (Carassius auratus) macrophage cell line , 1996, Immunology and cell biology.

[67]  H. Kolb,et al.  Pancreatic islet cells are highly susceptible towards the cytotoxic effects of chemically generated nitric oxide. , 1993, Biochimica et biophysica acta.

[68]  Susanne A. Fischer,et al.  The interleukin‐12 subunit p40 specifically inhibits effects of the interleukin‐12 heterodimer , 1993, European journal of immunology.

[69]  D. Gold,et al.  Nitric oxide and the immunomodulation of experimental allergic encephalomyelitis , 1997, European journal of immunology.

[70]  F. Marumo,et al.  Molecular cloning of endothelial, inducible nitric oxide synthase gene from rat aortic endothelial cell. , 1996, European journal of biochemistry.

[71]  J. Aten,et al.  Nitric oxide suppresses IFN-gamma production in the spleen of mercuric chloride-exposed brown Norway rats. , 1995, Cellular immunology.

[72]  M. Seldin,et al.  Clinical and Serologic Manifestations of Autoimmune Disease in MRL-lpr/lpr Mice Lacking Nitric Oxide Synthase Type 2 , 1997, The Journal of experimental medicine.

[73]  C. Bogdan,et al.  Type 1 Interferon (IFNα/β) and Type 2 Nitric Oxide Synthase Regulate the Innate Immune Response to a Protozoan Parasite , 1998 .

[74]  T. Kawamoto,et al.  Cloning and structural characterization of the human endothelial nitric-oxide-synthase gene. , 1994, European journal of biochemistry.

[75]  H. Kroger,et al.  Suppression of inflammatory arthritis by simultaneous inhibition of nitric oxide synthase and NADPH oxidase. , 1996, Free radical biology & medicine.

[76]  J. Maclouf,et al.  Regulation of the expression of cyclooxygenase-2 by nitric oxide in rat peritoneal macrophages. , 1997, Journal of immunology.

[77]  D. Willoughby,et al.  Induction of cyclo-oxygenase and nitric oxide synthase in inflammation. , 1996, Advances in pharmacology.

[78]  S. Moncada,et al.  The role of TH1 and TH2 cells in a rodent malaria infection. , 1993, Science.

[79]  V. Singh,et al.  The paradigm of Th1 and Th2 cytokines , 1999, Immunologic research.

[80]  H. Kolb,et al.  Activated macrophages kill pancreatic syngeneic islet cells via arginine-dependent nitric oxide generation. , 1991, Biochemical and biophysical research communications.

[81]  C. Nathan,et al.  Role of nitric oxide synthesis in macrophage antimicrobial activity. , 1991, Current opinion in immunology.

[82]  C. Chang,et al.  Molecular Cloning and Expression of an Avian Macrophage Nitric-oxide Synthase cDNA and the Analysis of the Genomic 5′-Flanking Region (*) , 1996, The Journal of Biological Chemistry.

[83]  D. Bredt,et al.  Perspectives Series : Nitric Oxide and Nitric Oxide Synthases Nitric Oxide in Excitable Tissues : Physiological Roles and Disease , 2013 .

[84]  N. Welsh,et al.  Nitric oxide and pancreatic beta-cell destruction in insulin dependent diabetes mellitus: don't take NO for an answer. , 1994, Autoimmunity.

[85]  S. Narula,et al.  Expression of human inducible nitric oxide synthase in Escherichia coli , 1996, FEBS letters.

[86]  Shuibang Wang,et al.  Endogenously Produced Nitric Oxide Increases Tumor Necrosis Factor-α Production in Transfected Human U937 Cells , 1997 .

[87]  M. Marletta,et al.  Nitric oxide synthase structure and mechanism. , 1993, The Journal of biological chemistry.

[88]  S. Moncada,et al.  The L-arginine-nitric oxide pathway. , 1993, The New England journal of medicine.

[89]  S. Erzurum,et al.  Continuous nitric oxide synthesis by inducible nitric oxide synthase in normal human airway epithelium in vivo. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[90]  G. Vallortigara,et al.  Right-pawedness in toads , 1996, Nature.

[91]  C. Nathan,et al.  Nitric oxide and macrophage function. , 1997, Annual review of immunology.

[92]  J. Forrester,et al.  Nitric oxide accelerates the onset and increases the severity of experimental autoimmune uveoretinitis through an IFN-gamma-dependent mechanism. , 1997, Journal of immunology.

[93]  W. Farrar,et al.  Nitric oxide and thiol redox regulation of Janus kinase activity. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[94]  C. Kablitz,et al.  Evidence for cytokine-inducible nitric oxide synthesis from L-arginine in patients receiving interleukin-2 therapy. , 1992, The Journal of clinical investigation.

[95]  R. Sobel,et al.  Inhibition of nitric oxide synthase for treatment of experimental autoimmune encephalomyelitis. , 1997, Journal of immunology.

[96]  C. Cockerell,et al.  Nitric oxide: A physiologic messenger: Lowenstein CJ, Dinerman JL, Snyder SH. Ann Intern Med 1994;120:227–237 , 1995 .

[97]  M. Mcdaniel,et al.  Does Nitric Oxide Mediate Autoimmune Destruction of β-Cells?: Possible Therapeutic Interventions in IDDM , 1992, Diabetes.